Chemoinformaics analysis of Cycloartomunoxanthone
Molecular Weight | 448.471 | nRot | 1 |
Heavy Atom Molecular Weight | 424.279 | nRig | 30 |
Exact Molecular Weight | 448.152 | nRing | 6 |
Solubility: LogS | -3.165 | nHRing | 3 |
Solubility: LogP | 6.176 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
nHA | 7 | APOL | 65.037 |
nHD | 2 | BPOL | 31.889 |
QED | 0.548 |
Synth | 4.027 |
Natural Product Likeliness | 2.895 |
NR-PPAR-gamma | 0.658 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.962 |
Pgp-sub | 0.001 |
HIA | 0.13 |
CACO-2 | -4.997 |
MDCK | 0.0000188 |
BBB | 0.004 |
PPB | 0.987896 |
VDSS | 0.418 |
FU | 0.027939 |
CYP1A2-inh | 0.221 |
CYP1A2-sub | 0.855 |
CYP2c19-inh | 0.276 |
CYP2c19-sub | 0.147 |
CYP2c9-inh | 0.841 |
CYP2c9-sub | 0.885 |
CYP2d6-inh | 0.125 |
CYP2d6-sub | 0.236 |
CYP3a4-inh | 0.231 |
CYP3a4-sub | 0.242 |
CL | 1.96 |
T12 | 0.096 |
hERG | 0.006 |
Ames | 0.296 |
ROA | 0.966 |
SkinSen | 0.148 |
Carcinogencity | 0.778 |
EI | 0.043 |
Respiratory | 0.774 |
NR-Aromatase | 0.962 |
Antiviral | Yes |
Prediction | 0.749362 |